Author: EconLearner
As is now known, former President Trump is currently on trial in New York. The charges are that he fraudulently inflated the value of his assets to secure better lending terms from banks and insurance companies. What a laugh. And the last one is not a partisan remark. If readers are in doubt, feel free to Google GOOG “John Tamney” with “Donald Trump” reading comments about him going back to at least 2009. Some were positive, some were middle of the road, but the vast majority were negative. Back to the lawsuit against Trump, it’s funny on the face of…
getty Trust in higher education falls with it college enrollment. Many prospective students are no longer confident that a traditional college degree will equip them with the skills needed to succeed in the job market. There is a demand for alternative solutions: a American Compass Survey found that, by a 57-43 margin, parents would rather have their own children participate in a three-year apprenticeship than attend college on a full scholarship. Politicians of both parties talk about expanding apprenticeships. But Ryan Craig has a plan to do just that. Craig’s new book, “Apprentice Nation: How Alternative Higher Education Will Create…
Afghan refugees gather in a makeshift camp upon their arrival from Pakistan, near … [+] The Afghanistan-Pakistan Torkham border in Nangarhar province on November 2, 2023. Thousands of Afghans have fled Pakistan this month since its government ordered 1.7 million people to leave or face arrest and deportation, officials said on November 2 . (Photo by Wakil KOHSAR / AFP ) (Photo by WAKIL KOHSAR/AFP via Getty Images)AFP via Getty Images In October 2023, the Pakistani government announced that it would arrest and deport hundreds of thousands of unregistered foreign nationals and undocumented immigrants. The deadline was set for November…
This is the conclusion of his recent research Hetana AharKellogg assistant professor of marketing.Achar wanted to understand whether our desire to protect our self-image would make us less likely to take healthy actions if the relevant health problems were directly linked to stigmatized behaviors.Take cervical cancer for example. “Regular cervical cancer screening is a healthy, beneficial practice,” she says. “But having multiple sexual partners, a risk factor for cervical cancer, is stigmatized in many societies. In such societies, some people may put their health at risk to avoid being associated with something that others think is ‘bad’.”Achar et al Leah…
But Dranovprofessor of strategy, admits that when he lectures on innovation, he has the nagging feeling that something important is missing from what he presents: innovation not of drugs but of medical procedures.”I always think about the fact that everything we seem to know about medical innovation, at least from academic research, comes from drugs and biologics, with maybe only a little from medical devices,” he says. “And yet, when you look at some of the most important medical innovations, they are innovations in new medicine procedures”—such as open-heart surgery, joint replacement surgery, kidney dialysis, and various mental health treatments.Although…
They are all products made by companies that have been prosecuted for price fixing by the US Department of Justice. In reality, industry players operated as a cartel, colluding to set high prices.While the idea of a cartel may bring to mind shadowy groups that distribute illegal products, the concept is also relevant to everyday business. “It’s not always sophisticated criminals and dark alleys,” he says Amanda Stark, associate professor of strategy at the Kellogg School. “And, in this case, they’re very bad at it.” However, it is still a crime with a large negative impact on consumers, who are…
According to a new study from the Kellogg School, you’ll likely take more precautions against a sneaky agent than a plain old virus. Research shows that people are more likely to comply with health recommendations when diseases are anthropomorphized and given human characteristics, such as names, personalities or jobs.”If you think about a disease in human terms, you’ll be more likely to try to avoid it,” he says Maferima Touré-Tillery, associate professor of marketing. At the same time he wrote the newspaper Lily Wang of Zhejiang University and Ann L. McGill of the University of Chicago Booth School of Business.Previous…
This futuristic scenario is an example of how artificial intelligence can become part of healthcare. In fact, artificial intelligence systems are already being developed to read medical scans and tissue samples to determine whether a patient has a disease. Future software could analyze patterns in thousands of health records to identify the most effective treatment for a particular patient—for example, which cancer treatment might work best given their genetic makeup.In a recent paper, David Dranov and Craig Garthwaiteprofessors of strategy at Kellogg, explored the implications of integrating artificial intelligence into healthcare – specifically, how such software will affect the central…
“In many markets we think choice is a good thing,” says Starc. “People have different preferences and may want different things. If I give you three options instead of two, then worst case scenario, if the third option doesn’t work for you, just don’t take it, right?”But the health insurance market may not follow that rule of thumb because in this sector, unlike, say, groceries or electronics, “the cost depends on who’s buying the product,” says Starc. While insurers can no longer refuse to serve people with existing medical conditions or charge them higher premiums, factors such as age and…
Politically, this is a popular move. According polls, Americans across the political spectrum support the administration’s plan, which Democrats have proposed in various forms for more than two decades. The Congressional Budget Office says the program, triggered by last year’s Inflation Reduction Act, will save taxpayers $98 billion over the next decade.Less enthusiastic are pharmaceutical companies, which face extremely heavy fines or the loss of a huge customer base if they choose not to participate in the Medicare negotiations. (After private health insurance, Medicare is the second-largest buyer of pharmaceuticals, accounting for 30 percent of sales.) These companies say the…